Alliance Cancer Care to upgrade cancer care in southeastern U.S. with Elekta solutions

HUNTSVILLE US — Tuesday, June 20, 2017

Elekta (EKTA-B.ST) announced today that Alliance Cancer Care (ACC) has acquired advanced treatment and software solutions to best serve patients receiving treatment at their four sites in the Huntsville and Decatur areas. The technology will be equipped to optimize patient care with stereotactic radiosurgery (SRS), and stereotactic body radiation therapy (SBRT), delivering high definition dynamic radiosurgery.

The four partner sites will add five Versa HD™ linear accelerators, as well as intelligent software from Elekta, including Monaco® treatment planning system and MOSAIQ® Oncology Analytics. The Versa HD systems will be equipped with Brainlab ExacTrac® patient positioning and monitoring technology. This combined solution will allow ACC to create a state-of-the-art linac-based SRS program.

Many tumors located near critical organs or difficult-to-access areas require a level of precision not achievable with traditional linear accelerators, and the goal of this program would be to offer this option to patients with these advanced technologies.

“I believe that this collaboration will allow us to fulfill multiple goals,” says Hoyt A. ‘Tres’ Childs, III, MD, Alliance Cancer Care. “Elekta has proven itself as an innovator and their commitment to develop stereotactic radiation therapies will help improve treatment rates while having fewer side effects during that treatment. Alliance Oncology is a proven leader in radiation oncology and our expertise is best exemplified in SRS programs, providing better care for our patients – and offered closer to home.”

“We are excited to bring together an aligned initiative for enhancing cancer care in the northern Alabama market,” says Allison Loehr, Vice President, Business Development & Vendor Partnerships, Alliance Oncology. “In partnering directly with hospitals, physicians and other healthcare providers, we establish a fully integrated, comprehensive approach to cancer care which affords its partners the speed-to-market, quality clinical outcomes, and operational expertise.”

“The clinical team at Alliance Cancer Care are front-runners in the pursuit of the highest quality of care for their patients,” says Len Lyons, VP of Elekta Enterprise Solutions. Elekta is very excited to partner with the leadership team and clinicians at ACC to deliver life-saving cancer treatment solutions, delivered on the most technologically advanced equipment available in our industry. We are particularly eager to further collaborate with ACC to streamline and optimize the delivery of this exceptional care through the creative application of Elekta’s market-leading MOSAIQ software and data intelligence solutions.”

About Elekta

Elekta is proud to be the leading innovator of equipment and software used to improve, prolong and save the lives of people with cancer and brain disorders. Our advanced, effective solutions are created in collaboration with customers, and more than 6,000 hospitals worldwide rely on Elekta technology. Our treatment solutions and oncology informatics portfolios are designed to enhance the delivery of radiation therapy, radiosurgery and brachytherapy, and to drive cost efficiency in clinical workflows. Elekta employs 3,600 people around the world. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm.